A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Clinical trial NCT06318169 · RECRUITING

Trial details

NCT number: NCT06318169
Sponsor: 89bio, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Start date: 2024-03-13
Primary completion: 2029-02-01
Enrollment: 1350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.